184 related articles for article (PubMed ID: 36638794)
1. Structures of the entire human opioid receptor family.
Wang Y; Zhuang Y; DiBerto JF; Zhou XE; Schmitz GP; Yuan Q; Jain MK; Liu W; Melcher K; Jiang Y; Roth BL; Xu HE
Cell; 2023 Jan; 186(2):413-427.e17. PubMed ID: 36638794
[TBL] [Abstract][Full Text] [Related]
2. Capsaicin inhibits the in vitro binding of peptides selective for mu- and kappa-opioid, and nociceptin-receptors.
Wollemann M; Ioja E; Benyhe S
Brain Res Bull; 2008 Sep; 77(2-3):136-42. PubMed ID: 18588953
[TBL] [Abstract][Full Text] [Related]
3. Complete knockout of the nociceptin/orphanin FQ receptor in the rat does not induce compensatory changes in mu, delta and kappa opioid receptors.
Homberg JR; Mul JD; de Wit E; Cuppen E
Neuroscience; 2009 Sep; 163(1):308-15. PubMed ID: 19527777
[TBL] [Abstract][Full Text] [Related]
4. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
[TBL] [Abstract][Full Text] [Related]
5. Glycinergic inputs to cardiac vagal neurons in the nucleus ambiguus are inhibited by nociceptin and mu-selective opioids.
Venkatesan P; Baxi S; Evans C; Neff R; Wang X; Mendelowitz D
J Neurophysiol; 2003 Sep; 90(3):1581-8. PubMed ID: 12761284
[TBL] [Abstract][Full Text] [Related]
6. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
7. Peptide-derived ligands for the discovery of safer opioid analgesics.
Eliasof A; Liu-Chen LY; Li Y
Drug Discov Today; 2024 May; 29(5):103950. PubMed ID: 38514040
[TBL] [Abstract][Full Text] [Related]
8. Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach.
Webster L; Schmidt WK
Pain Med; 2020 May; 21(5):992-1004. PubMed ID: 31165885
[TBL] [Abstract][Full Text] [Related]
9. Endogenous opioid peptides and brain development: Endomorphin-1 and Nociceptin play a sex-specific role in the control of oligodendrocyte maturation and brain myelination.
Mohamed E; Paisley CE; Meyer LC; Bigbee JW; Sato-Bigbee C
Glia; 2020 Jul; 68(7):1513-1530. PubMed ID: 32065429
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.
Toll L; Khroyan TV; Polgar WE; Jiang F; Olsen C; Zaveri NT
J Pharmacol Exp Ther; 2009 Dec; 331(3):954-64. PubMed ID: 19773529
[TBL] [Abstract][Full Text] [Related]
11. Biased Opioid Ligands.
Faouzi A; Varga BR; Majumdar S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
[TBL] [Abstract][Full Text] [Related]
12. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.
Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE
Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306
[TBL] [Abstract][Full Text] [Related]
13. An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects.
French AR; van Rijn RM
Pharmacol Res; 2022 Mar; 177():106091. PubMed ID: 35101565
[TBL] [Abstract][Full Text] [Related]
14. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
Gomes I; Fujita W; Gupta A; Saldanha SA; Negri A; Pinello CE; Eberhart C; Roberts E; Filizola M; Hodder P; Devi LA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12072-7. PubMed ID: 23818586
[TBL] [Abstract][Full Text] [Related]
15. Opioids in chronic pain.
Przewłocki R; Przewłocka B
Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
[TBL] [Abstract][Full Text] [Related]
16. Designing Safer Analgesics via μ-Opioid Receptor Pathways.
Chan HCS; McCarthy D; Li J; Palczewski K; Yuan S
Trends Pharmacol Sci; 2017 Nov; 38(11):1016-1037. PubMed ID: 28935293
[TBL] [Abstract][Full Text] [Related]
17. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
18. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene.
Clarke S; Chen Z; Hsu MS; Pintar J; Hill R; Kitchen I
Brain Res; 2001 Jul; 906(1-2):13-24. PubMed ID: 11430857
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists.
Wang H; Hetzer F; Huang W; Qu Q; Meyerowitz J; Kaindl J; Hübner H; Skiniotis G; Kobilka BK; Gmeiner P
Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200269. PubMed ID: 35385593
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.
Fujita W; Gomes I; Dove LS; Prohaska D; McIntyre G; Devi LA
Biochem Pharmacol; 2014 Dec; 92(3):448-56. PubMed ID: 25261794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
